ATE361913T1 - Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren - Google Patents
Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitorenInfo
- Publication number
- ATE361913T1 ATE361913T1 AT01966367T AT01966367T ATE361913T1 AT E361913 T1 ATE361913 T1 AT E361913T1 AT 01966367 T AT01966367 T AT 01966367T AT 01966367 T AT01966367 T AT 01966367T AT E361913 T1 ATE361913 T1 AT E361913T1
- Authority
- AT
- Austria
- Prior art keywords
- protease inhibitors
- intermediate products
- retroviral protease
- producing retroviral
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65191900A | 2000-08-31 | 2000-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE361913T1 true ATE361913T1 (de) | 2007-06-15 |
Family
ID=24614772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01966367T ATE361913T1 (de) | 2000-08-31 | 2001-08-29 | Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1313712B1 (de) |
JP (1) | JP5021141B2 (de) |
KR (1) | KR100806533B1 (de) |
CN (1) | CN1264823C (de) |
AT (1) | ATE361913T1 (de) |
AU (1) | AU2001286889A1 (de) |
BR (1) | BR0108146A (de) |
CA (2) | CA2731273C (de) |
CY (1) | CY1106738T1 (de) |
DE (1) | DE60128367T2 (de) |
DK (1) | DK1313712T3 (de) |
ES (1) | ES2284684T3 (de) |
HK (1) | HK1057040A1 (de) |
IL (1) | IL153436A0 (de) |
MX (1) | MXPA03001751A (de) |
PT (1) | PT1313712E (de) |
WO (1) | WO2002018349A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE539074T1 (de) * | 2003-12-11 | 2012-01-15 | Abbott Lab | Die hiv-protease hemmende verbindungen |
CN100358521C (zh) * | 2004-12-28 | 2008-01-02 | 哈尔滨欧替药业股份有限公司 | 一种双唑泰栓剂及其制备工艺 |
CN103910634B (zh) * | 2012-12-29 | 2018-04-27 | 广东东阳光药业有限公司 | 西格列汀中间体的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5914332A (en) * | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
-
2001
- 2001-08-29 CA CA2731273A patent/CA2731273C/en not_active Expired - Lifetime
- 2001-08-29 ES ES01966367T patent/ES2284684T3/es not_active Expired - Lifetime
- 2001-08-29 PT PT01966367T patent/PT1313712E/pt unknown
- 2001-08-29 BR BR0108146-2A patent/BR0108146A/pt not_active Application Discontinuation
- 2001-08-29 WO PCT/US2001/026898 patent/WO2002018349A2/en active IP Right Grant
- 2001-08-29 CN CNB018148646A patent/CN1264823C/zh not_active Expired - Lifetime
- 2001-08-29 DK DK01966367T patent/DK1313712T3/da active
- 2001-08-29 DE DE60128367T patent/DE60128367T2/de not_active Expired - Lifetime
- 2001-08-29 AT AT01966367T patent/ATE361913T1/de active
- 2001-08-29 AU AU2001286889A patent/AU2001286889A1/en not_active Abandoned
- 2001-08-29 KR KR1020037002869A patent/KR100806533B1/ko active IP Right Grant
- 2001-08-29 MX MXPA03001751A patent/MXPA03001751A/es active IP Right Grant
- 2001-08-29 EP EP01966367A patent/EP1313712B1/de not_active Expired - Lifetime
- 2001-08-29 CA CA2416955A patent/CA2416955C/en not_active Expired - Lifetime
- 2001-08-29 IL IL15343601A patent/IL153436A0/xx active IP Right Grant
- 2001-08-29 JP JP2002523467A patent/JP5021141B2/ja not_active Expired - Lifetime
-
2003
- 2003-10-17 HK HK03107574A patent/HK1057040A1/xx not_active IP Right Cessation
-
2007
- 2007-07-16 CY CY20071100952T patent/CY1106738T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002018349A3 (en) | 2002-05-10 |
CA2731273A1 (en) | 2002-03-07 |
DE60128367D1 (de) | 2007-06-21 |
WO2002018349A2 (en) | 2002-03-07 |
BR0108146A (pt) | 2004-01-06 |
HK1057040A1 (en) | 2004-03-12 |
CA2416955A1 (en) | 2002-03-07 |
ES2284684T3 (es) | 2007-11-16 |
KR100806533B1 (ko) | 2008-02-25 |
CY1106738T1 (el) | 2012-05-23 |
KR20030061787A (ko) | 2003-07-22 |
DE60128367T2 (de) | 2008-01-10 |
IL153436A0 (en) | 2003-07-06 |
MXPA03001751A (es) | 2003-09-10 |
EP1313712B1 (de) | 2007-05-09 |
CA2731273C (en) | 2013-10-15 |
CN1264823C (zh) | 2006-07-19 |
AU2001286889A1 (en) | 2002-03-13 |
CA2416955C (en) | 2011-04-26 |
JP5021141B2 (ja) | 2012-09-05 |
JP2004507528A (ja) | 2004-03-11 |
DK1313712T3 (da) | 2007-09-10 |
CN1449388A (zh) | 2003-10-15 |
PT1313712E (pt) | 2007-07-25 |
EP1313712A2 (de) | 2003-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60320362D1 (de) | Verfahren zur Herstellung von Dipeptiden | |
BR0215405A (pt) | Composições e processos de uso de collajolie | |
DK0920410T3 (da) | Fremgangsmåde til fremstilling af cyclohexencarboxylatderivater | |
ATE449104T1 (de) | Verfahren zur reinigung von fibrinogen | |
ATE282607T1 (de) | Tryptase-inhibitoren | |
EA199800844A1 (ru) | Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе | |
ATE204851T1 (de) | Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten | |
DE60327936D1 (de) | Modulatoren von ship-1 | |
BR0312889A (pt) | Polipeptìdeo t20 peguilado | |
WO2004046293A3 (en) | Amphoteric fluorescent whitening agents | |
DE69808475D1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
DE59900730D1 (de) | Korrosionsinhibitoren enthaltender Injektionszement | |
ATE361913T1 (de) | Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren | |
DE60213874D1 (de) | Verfahren zur herstellung von protease hemmenden zwischenprodukten | |
DE50309260D1 (de) | Verfahren zur herstellung von bicalutamid | |
DE69908761D1 (de) | Verfahren zur herstellung von hiv-protease inhibitoren | |
ATE325794T1 (de) | Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin | |
DE602004031129D1 (de) | Verfahren zur herstellung von quetiapin | |
DE60325390D1 (de) | Verfahren zur herstellung von zwischenprodukten | |
SE9800865D0 (sv) | New Process | |
ATE327987T1 (de) | Methylthiophencarboxanilide | |
DE69922999D1 (de) | Verfahren zur herstellung von polyhalogenierten para-trifluoroanilinen | |
DE10295581D2 (de) | Verfahren zur Synthese von All-D-Peptiden | |
DE50312447D1 (de) | Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin | |
TW200505413A (en) | Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1313712 Country of ref document: EP |